ARCHIVES

Micafungin Bests Fluconazole In Phase III Antifungal Trial

This article is from The Cancer Letter archive.

Vol. 25 No. 11 | November 29, 2002

Download PDF Visit The Full Archive

Related Articles

Some Tumors Show Partial Response To Drug Combo

January 27, 2006

NCCS Networker Volume 9 Issue 1, Spring 1995

April 13, 1995

Also: NCCN Committee Reaffirms Clinical Guideline Covering Avastin for Breast Cancer Indication

July 22, 2011

Study Links Native American Ancestry to Leukemia Relapse

February 25, 2011

After 30 Years As NCI-Designated Center, Vermont Cancer Center Loses Core Grant.

November 14, 2008

In Brief: The Anatomy Of An Administrative Nightmare: How NIH Spent $518 Million In One Day

October 23, 1992